1987
DOI: 10.1002/1097-0142(19870501)59:9<1566::aid-cncr2820590906>3.0.co;2-z
|View full text |Cite
|
Sign up to set email alerts
|

Malignant histiocytosis. Complete remission in two pediatric patients

Abstract: The experience with the treatment of malignant histiocytosis has been disappointing. Despite modest treatment success with a combination of cyclophosphamide, Adriamycin (doxorubicin), vincristine and prednisone, the overall prognosis remains poor. There are only a few reports of prolonged complete remissions in pediatric patients. The following report describes two children who have had long-term remission with an aggressive combination chemotherapy program that included intrathecal prophylaxis. The chemothera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
1998
1998

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 19 publications
(1 reference statement)
0
1
0
Order By: Relevance
“…Therefore, all therapeutic interventions were directed at the management of malignant histiocytosis. However, despite encouraging recent results using doxorubicin-and cyclophosphamide-containing regimens in this disorder [14,15], our patient's disease was refractory to all therapies and pursued a fulminant course. This has been the uniform outcome in previously reported patients with hematologic disorders and mediastinal germ cell tumors.…”
Section: Discussionmentioning
confidence: 66%
“…Therefore, all therapeutic interventions were directed at the management of malignant histiocytosis. However, despite encouraging recent results using doxorubicin-and cyclophosphamide-containing regimens in this disorder [14,15], our patient's disease was refractory to all therapies and pursued a fulminant course. This has been the uniform outcome in previously reported patients with hematologic disorders and mediastinal germ cell tumors.…”
Section: Discussionmentioning
confidence: 66%